Abstract:Copper plays an important role in tumor angiogenesis. Copper chelation has been confirmed as an effective strategy to inhibit tumor growth and metastasis via the suppression of tumor angiogenesis. Though small molecule copper chelator, TM, has been tested in clinical trials of breast cancer, some unavoidable side effects limit its potency, probably resulting from TM nonselectively eliminating copper from the whole body. In this work, a copper chelating coil-comb block copolymer RGDPEG-b-P(GA-g-(TETA-DTC-PHis))n (RPTDH) possessing tumor-targeting capability and pHsensitivity was synthesized and used to prepare nanoparticles for loading and controlled release of the immunoregulator R848. The linear segment of the copolymer consisted of hydrophilic PEG chain with RGD end group, which aims to target tumor microenvironment. The backbone of the comb segment was composed of biodegradable poly-γ-glutamic acid, and the side chain of the comb segment contained triethylenetetramine-bis(dithiocarbamate) midblock and poly-L-histidine block. The comb segments of triethylenetetramine-bis(dithiocarbamate) were used to chelate copper, while poly-Lhistidine was introduced to form hydrophobic core at weak alkali conditions to load R848, a TLR7/8 agonist, thus combining antiangiogenesis and immunotherapy to treat breast cancer. RPTDH/R848 nanoparticles significantly inhibited the mobility, invasion and vascular tube formation of HUVEC cells via copper chelation. In weakly acid media simulating tumor microenvironment, R848 was efficiently released from RPTDH/R848 nanoparticles and exhibited strong efficacy in the activation of human pDC-like CAL-1 cells. In breast tumor-bearing mice, RPTDH/R848 nanoparticles displayed excellent targeting ability for both tumor in situ and lung metastases, and furthermore dramatically inhibited tumor growth and metastasis through angiogenesis suppression and CD8 T cells accumulation in tumor microenvironment. In conclusion, RPTDH/R848 nanoparticles significantly suppress breast cancer growth and metastasis by combining antiangiogenesis with immunotherapy.

Polymer/copper Nanocomplex-Induced Lysosomal Cell Death Promotes Tumor Lymphocyte Infiltration and Synergizes Anti-Pd-l1 Immunotherapy for Triple-Negative Breast Cancer

Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.

Copper‐Based Composites Nanoparticles Improve Triple‐Negative Breast Cancer Treatment with Induction of Apoptosis‐Cuproptosis and Immune Activation

Improving Anti-Pd-l1 Therapy in Triple Negative Breast Cancer by Polymer-Enhanced Immunogenic Cell Death and CXCR4 Blockade

Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy

Copper-Doped Nanoscale Covalent Organic Polymer for Augmented Photo/Chemodynamic Synergistic Therapy and Immunotherapy.

Mitochondria‐Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death‐1 Downregulation for Cancer Immunotherapy

Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy

The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death

Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy

Copper-Based Nanoscale Coordination Polymers Augmented Tumor Radioimmunotherapy for Immunogenic Cell Death Induction and T-Cell Infiltration.

Smart R848-Loaded Nanoparticles Based on Copper Chelate Copolymer for Combining Anti-Angiogenesis and Immunotherapy to Inhibit Breast Cancer Growth and Metastasis

Dendritic Polymer-Functionalized Nanomedicine Potentiates Immunotherapy Via Lethal Energy Crisis-Induced PD-L1 Degradation.

Tumor Microenvironmental Ph and Enzyme Dual Responsive Polymer-Liposomes for Synergistic Treatment of Cancer Immuno-Chemotherapy.

Synergistic Triple-Combination Therapy with Hyaluronic Acid-Shelled PPy/CPT Nanoparticles Results in Tumor Regression and Prevents Tumor Recurrence and Metastasis in 4T1 Breast Cancer.

Combining Anti-Pd-1 Antibodies with Mn2+-drug Coordinated Multifunctional Nanoparticles for Enhanced Cancer Therapy.

PD-L1 antibody conjugated dihydrotanshinone I-loaded polymeric nanoparticle for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death

Dynamic Polyphenol Nanoparticles Boost Cuproptosis-Driven Metalloimmunotherapy of Breast Cancer

Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death

Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression